Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2010
10/27/2010CN101869564A Medicinal composition taking dextrotolperisone as active ingredient
10/27/2010CN101869553A Bupropion hydrochloride sustained release tablets and preparation method thereof
10/27/2010CN101869545A Preparation method of embedded drug-loaded glucomannan and xanthan gum composite gel
10/27/2010CN101869270A Health product with drunkenness relieving and liver protecting functions
10/27/2010CN101869157A Health-care composition (Parkinson-resistant shockproof health-care tea) for preventing and treating PD (Parkinson Disease) and preparation method thereof
10/27/2010CN101574328B Timing pulsed release micro-pill of zolpidem salt
10/27/2010CN101496803B Application of compound taurine and ansiolin in preparing medicament for treating brain injury disease
10/27/2010CN101396355B Use of bilobalide B in preparing medicine for promoting nerve cell regenerate
10/27/2010CN101322718B Injection for reducing drug dependency and preparation thereof
10/27/2010CN101209171B Pillow containing tea, carbon and Chinese herbal medicine composite granules and preparation method thereof
10/27/2010CN101156877B A sobering-up agent
10/27/2010CN101081215B Conotoxin SO3 nanometer grain composition and method of making the same and the application thereof
10/27/2010CN101052639B Benzimidazole derivatives, composition containing thereof, its preparation method and application
10/27/2010CN101002589B Health-care medicine tea for sobering and taking care of liver and kidney
10/26/2010US7820876 Animal model for evaluating neurodegenerative disorders and identifying neuroprotective agents
10/26/2010US7820857 administering (R)-2-acetamido-N-benzyl-3-methoxypropionamide for treating neuropathic trigeminal pain
10/26/2010US7820814 Inhibitors of kinases
10/26/2010US7820792 isoform of the alpha 2 delta -4 subunit of a voltage gated calcium channel; useful to identify modulators of the channel subunit; for cancer and inflammation
10/26/2010US7820717 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis
10/26/2010US7820715 Chemical intermediates; neurodegenerative disorders
10/26/2010US7820714 Increased selectivity for sialic acid binding Ig-like lectins (Siglec); improving immune response dependent on B-cells
10/26/2010US7820695 Selective serotonin receptor inverse agonists as therapeutics for disease
10/26/2010US7820694 Administering an aminoindanyl derivative and; a steroid, dopamine receptor agonist or an anticholinergic or antimuscarinic agent; respiratory system disorders, antiallergens, chronic obstructive pulmonary disease, adult respiratory distress syndrome, bronchitis
10/26/2010US7820687 inflammatory diseases such as asthma, Alzheimer's disease, atherosclerosis, diabetes, autoimmune diseases, tumor metastasis and myocardial ischemia; improved bioavailability; 2-(2-(diethylamino)-5-(N-isopropylmethylsulfonamido)pyrimidin-4-ylamino)-3-(4-(pyrrolidine-1-carbonyloxy)phenyl)propanoic acid
10/26/2010US7820679 N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-′1,3,4-oxadiazol-2-yl-phenyl)pyridine-3 sulphonamide as an anticancer agent
10/26/2010US7820675 Benzofuran compounds
10/26/2010US7820658 such as 2-Amino-4-phenyl-thieno[2,3-d]pyrimidine-6-carboxylic acid ethylamide; veterinary medicine; anticancer agents
10/26/2010US7820643 Therapeutic treatment by administering milnacipran, a new use of existing pharmaceutical
10/26/2010US7820375 Use of a protein of the CRMP family for treating diseases related to the immune system
10/26/2010US7820170 monoclonal antibody exhibit antagonist activity of the anti-CD40 antibody; antiproliferative agents; controlling cell differentiation; anticarcinogenic agents; Hodgkin's disease, leukemias
10/26/2010US7820161 Treatment of autoimmune diseases
10/26/2010CA2661573C Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
10/26/2010CA2526893C Inhibition of the expression of huntingtin gene
10/26/2010CA2457780C Topical compositions and methods for treating pain
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/26/2010CA2434608C Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent
10/26/2010CA2422708C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
10/26/2010CA2418921C Novel composition
10/26/2010CA2417190C New beta-amyloid inhibitors, processes for preparing them and their use as pharmaceutical compositions
10/26/2010CA2412164C Amidine derivatives as selective antagonists of nmda receptors
10/26/2010CA2410594C Heterocyclic aminoalkylpyridine derivatives as psychopharmaceuticals
10/26/2010CA2409698C Neural progenitor cell populations
10/26/2010CA2409221C Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
10/26/2010CA2396956C Polypharmacophoric agents
10/26/2010CA2304700C Lipophilic diesters of chelating agents
10/26/2010CA2192928C Benzoheterocyclic derivatives
10/21/2010WO2010121225A2 Method of treating disorders associated with protein kinase ck2 activity
10/21/2010WO2010121023A2 Peptides and aptamers for targeting of neuron or nerves
10/21/2010WO2010121022A1 Monoamine reuptake inhibitors
10/21/2010WO2010120910A1 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
10/21/2010WO2010120872A2 Method of decreasing pro-adam10 secretase and/or beta secretase levels
10/21/2010WO2010120695A2 5-ht4 receptor agonist compounds for treatment of cognitive disorders
10/21/2010WO2010120237A1 Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase 3 related disorders such as alzheimer's disease
10/21/2010WO2010119990A1 Pharmaceutical compositions
10/21/2010WO2010119875A1 Fused pyrrolopyridine derivative
10/21/2010WO2010119864A1 Peptide derivative
10/21/2010WO2010119828A1 Method for culturing bone marrow stromal cells and mesenchymal stem cells, and method for producing graft cells for treating central neurological disease
10/21/2010WO2010119804A1 Anti-mental fatigue agent
10/21/2010WO2010119704A1 Antibodies that specifically bind to a beta oligomers and use thereof
10/21/2010WO2010119700A1 Novel compound having 3-heteroarylpyrimidin-4-(3h)-one structure and pharmaceutical preparation containing same
10/21/2010WO2010119344A1 Compounds for the treatment of mitochondrial diseases
10/21/2010WO2010119222A1 Derivatives of n-[(7-aza-bicyclo[2.2.1]hept-1-yl)-aryl-methyl]-benzamide, preparation thereof, and therapeutic use thereof
10/21/2010WO2010119161A2 Antiepileptic, hypocholesterolemic and neuroprotective compound
10/21/2010WO2010119078A1 Indole derivative modulators of the alpha 7 nachr
10/21/2010WO2010118921A1 Novel p2x7r antagonists and their use
10/21/2010WO2010118675A1 New use of neferine
10/21/2010WO2010100428A3 Protein kinase a and/or casein kinase ii for alleviating the inhibition of neurite outgrowth
10/21/2010WO2010077364A3 Stroke-generated angiogenesis enhancers and uses thereof
10/21/2010WO2010068877A3 Compounds that bind oxysterol binding proteins, and methods of use thereof
10/21/2010WO2010056985A3 Treatment of proteinopathies using a farnesyl transferase inhibitor
10/21/2010WO2010056044A3 Novel compound acting as a vanilloid receptor antagonist, isomer or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same
10/21/2010WO2009118516A8 Process for the preparation of donepezil hydrochloride
10/21/2010WO2009089024A8 Neuroactive steroid compositions and methods of use therefor
10/21/2010US20100267930 SLO2 and SLO4, Novel Potassium Channel Proteins from Human Brain
10/21/2010US20100267836 Novel melatonin ligands having antidepressant activity as well as sleep inducing properties
10/21/2010US20100267835 Methods of treating disorders of trigeminalvascular activation
10/21/2010US20100267834 Methods and pharmaceutical compositions for differentially altering gene expression to provide neuroprotection for the animal central nervous system against the effects of ischemia, neurodegeneration, trauma and metal poisoning
10/21/2010US20100267829 Pharmaceutical composition comprising low concentrations of environment pollutants
10/21/2010US20100267827 Phenyl-prenyl-ether derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders
10/21/2010US20100267823 Aurones as selective pde inhibitors and their use in neurological conditions and disorders
10/21/2010US20100267822 Aurones as estrogen receptor modulators and their use in sex hormone dependent diseases
10/21/2010US20100267816 Human anti-amyloid beta peptide antibody and fragment of said antibody
10/21/2010US20100267812 Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
10/21/2010US20100267807 Alleviating neuropathic pain with eets and seh inhibitors
10/21/2010US20100267800 N-Alkyl-Hydroxamic Acid-Isoindolyl Compounds and Their Pharmaceutical Uses
10/21/2010US20100267784 Novel 4,5-dihydroisoxazoles with estrogenic activity
10/21/2010US20100267782 Sodium channel inhibitors
10/21/2010US20100267781 Naphthalene-based inhibitors of anti-apoptotic proteins
10/21/2010US20100267780 Bicyclic aryl and heteroaryl receptor modulators
10/21/2010US20100267776 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
10/21/2010US20100267772 Combination of a Serotonin Reuptake Inhibitor and Agomelatine
10/21/2010US20100267769 Substituted Bicyclocarboxyamide Compounds
10/21/2010US20100267768 Process for making modulators of cystic fibrosis transmembrane conductance regulator
10/21/2010US20100267766 Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof
10/21/2010US20100267764 8-Aza-Bicyclo[3.2.1]Octane Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
10/21/2010US20100267763 Method of Decreasing Pro-ADAM10 Secretase and/or Beta Secretase Levels
10/21/2010US20100267762 Novel p2x7r antagonists and their use
10/21/2010US20100267761 7-Azaindole Derivatives as Selective 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors
10/21/2010US20100267760 Methods of and Combination Therapies for Treating or Delaying the Onset of Dyskinesia
10/21/2010US20100267756 Pharmaceutical preparation for treating demyelinating diseases of the nervous system; preparation promoting restoration of the myelin sheath of nerve fibers; and a method for treating demyelinating diseases of the nervous system
1 ... 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 ... 1833